Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The Phase 2 trial protocol specified that missed doses should not be doubled on the next injection day
Furthermore, BPC-157 exhibits anti-inflammatory properties through inhibition of pro-inflammatory cytokine production and modulation of nuclear factor-kappa B signaling pathways
In Novo Nordisk clinical trials it is being tested in combination with semaglutide (CagriSema) in Phase 3 obesity trials
Cross-Contamination: Never use the same syringe to draw from two different vials
5 days on, 2 days off, every week, across a 3-month active cycle
US$ 20.03
US$ 24.28
US$ 24.37
US$ 24.45
US$ 26.99
US$ 23.49
US$ 20.72
US$ 26.11
